Yunfeng Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yunfeng Hu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Yu Chang
Department of Radiation Oncology, Yan’an University Affiliated Hospital, Yan’an, China
4 shared publicationsYu Liu
Department of Radiation Oncology, Yan’an University Affiliated Hospital, Yan’an, China
3 shared publicationsXia Lei
Department of Gynecology, The First Affiliated Hospital of Yan’an University
2 shared publicationsBei Feng
Department of Oncology, The First Affiliated Hospital of Yan’an University, Yan’an, Shanxi, China
1 shared publicationHuahua Zhang
Medical Research and Experimental Center, Yan’an Medical College, Yan’an University
1 shared publicationJiale An
Nuclear Industry 215 Hospital of Shaanxi Province/215 Hospital of Shaanxi Province, Xian’yang, Shaanxi, China
1 shared publication
Latest Publications
- Open Access
- 22 February 2026
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1)
Screening and validation of potential molecular markers for colorectal cancer: based on bioinformatics analysis and machine learning
Colorectal Cancer (CRC) exhibits persistently high incidence and mortality rates worldwide, imposing a substantial socioeconomic burden. Early screening, early diagnosis, and early treatment can significantly improve patients’ survival rates while reducing mortality. However, there remains a lack of effective biomarkers to aid in early screening and diagnosis. As a branch of artificial intelligence, machine learning can automatically analyze large volumes of data, greatly saving human time and resources. The advancement of high-throughput sequencing technology has provided researchers with abundant gene expression data, offering rich data resources for the training and validation of machine learning models. With the development of artificial intelligence, integrating knowledge from bioinformatics, machine learning, molecular biology, and clinical medicine for analysis enables a more comprehensive understanding and exploration of the molecular biological mechanisms underlying CRC. In summary, this project aims to utilize machine learning techniques to screen five CRC signature genes (ABCG2, SCGN, USP2, CLDN1, and EPHX4) from GEO datasets, validate these signature genes using TCGA database, and perform RT-qPCR to detect the relative mRNA expression levels of these genes in CRC. Ultimately, this study seeks to provide novel biomolecular markers for the early diagnosis of CRC.
- 22 February 2026
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1)
Open AccessScreening and validation of potential molecular markers for colorectal cancer: based on bioinformatics analysis and machine learning
Colorectal Cancer (CRC) exhibits persistently high incidence and mortality rates worldwide, imposing a substantial socioeconomic burden. Early screening, early diagnosis, and early treatment can significantly improve patients’ survival rates while reducing mortality. However, there remains a lack of effective biomarkers to aid in early screening and diagnosis. As a branch of artificial intelligence, machine learning can automatically analyze large volumes of data, greatly saving human time and resources. The advancement of high-throughput sequencing technology has provided researchers with abundant gene expression data, offering rich data resources for the training and validation of machine learning models. With the development of artificial intelligence, integrating knowledge from bioinformatics, machine learning, molecular biology, and clinical medicine for analysis enables a more comprehensive understanding and exploration of the molecular biological mechanisms underlying CRC. In summary, this project aims to utilize machine learning techniques to screen five CRC signature genes (ABCG2, SCGN, USP2, CLDN1, and EPHX4) from GEO datasets, validate these signature genes using TCGA database, and perform RT-qPCR to detect the relative mRNA expression levels of these genes in CRC. Ultimately, this study seeks to provide novel biomolecular markers for the early diagnosis of CRC.
- Open Access
- 29 January 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1712621
Gastric cancer organoids: a promising model for personalized treatment of gastric cancer
Gastric cancer is one of the most prevalent malignant tumors in the gastrointestinal tract. At present, the main treatment methods of gastric cancer include chemotherapy, targeted therapy and immunotherapy. However, due to the strong heterogeneity of tumor cells, the current treatment schemes have different effects on each patient. Therefore, individualized treatment strategies for different patients have become an inevitable trend. The organoid model is an emerging technology for three-dimensional (3D) cell culture in vitro , which can simulate the three-dimensional structure of real organs and the interaction between cells, while retaining the heterogeneity of patients’ tumor cells. The response of organoid model to treatment can replace the response of patients’ tumor cells to treatment. Organoid model of gastric cancer can effectively bridge the basic research and clinical practice, and show remarkable transformation potential and broad application prospects in promoting individualized treatment of gastric cancer. In this paper, the establishment methods of organoid model of gastric cancer are systematically reviewed, and its application in drug sensitivity detection, biomarker discovery and mechanism research is discussed, in order to provide theoretical basis and practical reference for the development of precise treatment strategy for gastric cancer.
- 29 January 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1712621
Open AccessGastric cancer organoids: a promising model for personalized treatment of gastric cancer
Gastric cancer is one of the most prevalent malignant tumors in the gastrointestinal tract. At present, the main treatment methods of gastric cancer include chemotherapy, targeted therapy and immunotherapy. However, due to the strong heterogeneity of tumor cells, the current treatment schemes have different effects on each patient. Therefore, individualized treatment strategies for different patients have become an inevitable trend. The organoid model is an emerging technology for three-dimensional (3D) cell culture in vitro , which can simulate the three-dimensional structure of real organs and the interaction between cells, while retaining the heterogeneity of patients’ tumor cells. The response of organoid model to treatment can replace the response of patients’ tumor cells to treatment. Organoid model of gastric cancer can effectively bridge the basic research and clinical practice, and show remarkable transformation potential and broad application prospects in promoting individualized treatment of gastric cancer. In this paper, the establishment methods of organoid model of gastric cancer are systematically reviewed, and its application in drug sensitivity detection, biomarker discovery and mechanism research is discussed, in order to provide theoretical basis and practical reference for the development of precise treatment strategy for gastric cancer.
- Open Access
- 16 December 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1470739
Status quo and influencing factors of job burnout among residents in standardized training
Background: With the continuous progress and in-depth implementation of the reform of the medical and health care system, alongside the gradual enhancement of the standardized training framework for residents, such training has become a crucial avenue for cultivating high-level clinicians and improving medical quality. However, due to various constraints and limitations in their own capabilities, residents undergoing standardized training are often susceptible to job burnout during this process. Numerous factors contribute to job burnout, which is closely associated with depression and anxiety. To promote effective standardized training and develop high-quality resident personnel, it is essential to investigate the influencing factors of job burnout and implement strategies to mitigate its occurrence.Objective: Explore the job burnout and its influencing factors among standardized training residents of Affiliated Hospital of Yan ‘an University, and to provide favorable basis for effective prevention of job burnout.Methods: An online questionnaire survey was conducted among all standardized training residents at the hospital from June 2020 to September 2022. The evaluation utilized a general situation questionnaire, the Job Burnout Inventory - General Survey (MBI-GS), the Self-Rating Anxiety Scale (SAS), and the Self-Rating Depression Scale (SDS).Results: A total of 660 valid questionnaires were collected, and 315 people had positive reaction for job burnout, and the detection rate was 47.7%. Difference in gender, marital status, whether they held practicing certificates, participated in work before training, used sleep medication, age, grade, sleep state were the influencing factors of different dimensions of job burnout. 175 people were in a state of anxiety (26.5%), while 357 (54.1%) were depressed. Pearson correlation analysis showed that anxiety and depression were highly correlated with job burnout (p < 0.01). The results of multi-factor analysis showed that sleep status, whether to take sleep AIDS, anxiety and depression were the factors affecting the dimension of emotional exhaustion (p < 0.01). Income, sleep status, anxiety and depression scores were the influencing factors of job burnout dimension (p < 0.05). Sleep status and depression score were the factors affecting the dimension of reduced sense of achievement (p < 0.05).Conclusion: Job burnout is prevalent among residents undergoing standardized training, and the factors influencing it are numerous and diverse. It is closely associated with various elements such as age, income, years of training, sleep quality, anxiety, and depression. Therefore, it is recommended to implement appropriate measures to mitigate the occurrence of job burnout and enhance the quality of standardized training for residents. Such measures may include formulating reasonable training policies and theoretical learning plans, as well as providing mental health interventions.
- 16 December 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1470739
Open AccessStatus quo and influencing factors of job burnout among residents in standardized training
Background: With the continuous progress and in-depth implementation of the reform of the medical and health care system, alongside the gradual enhancement of the standardized training framework for residents, such training has become a crucial avenue for cultivating high-level clinicians and improving medical quality. However, due to various constraints and limitations in their own capabilities, residents undergoing standardized training are often susceptible to job burnout during this process. Numerous factors contribute to job burnout, which is closely associated with depression and anxiety. To promote effective standardized training and develop high-quality resident personnel, it is essential to investigate the influencing factors of job burnout and implement strategies to mitigate its occurrence.Objective: Explore the job burnout and its influencing factors among standardized training residents of Affiliated Hospital of Yan ‘an University, and to provide favorable basis for effective prevention of job burnout.Methods: An online questionnaire survey was conducted among all standardized training residents at the hospital from June 2020 to September 2022. The evaluation utilized a general situation questionnaire, the Job Burnout Inventory - General Survey (MBI-GS), the Self-Rating Anxiety Scale (SAS), and the Self-Rating Depression Scale (SDS).Results: A total of 660 valid questionnaires were collected, and 315 people had positive reaction for job burnout, and the detection rate was 47.7%. Difference in gender, marital status, whether they held practicing certificates, participated in work before training, used sleep medication, age, grade, sleep state were the influencing factors of different dimensions of job burnout. 175 people were in a state of anxiety (26.5%), while 357 (54.1%) were depressed. Pearson correlation analysis showed that anxiety and depression were highly correlated with job burnout (p < 0.01). The results of multi-factor analysis showed that sleep status, whether to take sleep AIDS, anxiety and depression were the factors affecting the dimension of emotional exhaustion (p < 0.01). Income, sleep status, anxiety and depression scores were the influencing factors of job burnout dimension (p < 0.05). Sleep status and depression score were the factors affecting the dimension of reduced sense of achievement (p < 0.05).Conclusion: Job burnout is prevalent among residents undergoing standardized training, and the factors influencing it are numerous and diverse. It is closely associated with various elements such as age, income, years of training, sleep quality, anxiety, and depression. Therefore, it is recommended to implement appropriate measures to mitigate the occurrence of job burnout and enhance the quality of standardized training for residents. Such measures may include formulating reasonable training policies and theoretical learning plans, as well as providing mental health interventions.
- Open Access
- 11 October 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1481266
MicroRNA-582-5p inhibits the progression of gastric cancer cells and their resistance to oxaliplatin by suppressing ATG7 expression
Background: Gastric cancer (GC) is one of the most common malignant tumors of the digestive tract worldwide. Both environmental and genetic factors contribute to the occurrence and development of GC. Surgery and chemotherapy are the main treatment modalities for gastric cancer; however, some patients show insensitivity to chemotherapeutic agents. Chemotherapy resistance is one of the primary reasons for poor treatment outcomes and the high likelihood of recurrence and metastasis in gastric cancer patients. Numerous studies have confirmed a correlation between the dysregulation of microRNA expression and the development of various malignant tumors, as well as their resistance to chemotherapeutic agents. However, the role of microRNA-582-3p in gastric cancer cells and its mechanism in the resistance of gastric cancer cells to oxaliplatin have not been studied.Methods: We first used q-PCR, CCK8, transwell, and scratch assays to validate the expression of microRNA-582-3p in gastric cancer tissues and cells, while also analyzing the relationship between its expression levels and the clinical pathological data of patients. Additionally, we further confirmed the impact of microRNA-582-3p on gastric cancer cell progression and oxaliplatin resistance through knockdown and overexpression experiments. Subsequently, to explore the specific mechanisms of microRNA-582-3p in gastric cancer, we verified the downstream target of microRNA-582-3p, ATG7, using dual-luciferase reporter assays and examined the effect of ATG7 on gastric cancer cell functions. Moreover, we conducted rescue experiments to further validate the interaction between microRNA-582-3p and ATG7.Results: Our experimental results confirmed that microRNA-582-3p is lowly expressed in gastric cancer tissues and cells, and the expression level of miR-582-5p is correlated with the T stage of patients, while showing no correlation with the patients' gender, age, tumor size, degree of differentiation, or N stage. Additionally, we found that microRNA-582-3p functions as a tumor suppressor in gastric cancer cells, as its overexpression inhibits the biological functions of gastric cancer cells and increases their sensitivity to oxaliplatin. Furthermore, we identified binding sites between microRNA-582-3p and the autophagy-related gene ATG7, observing that knockdown of microRNA-582-3p increases ATG7 expression, while its overexpression reduces ATG7 levels. Moreover, ATG7 is overexpressed in gastric cancer cells; knockdown of ATG7 inhibits the biological functions of gastric cancer cells and increases their sensitivity to oxaliplatin, whereas overexpression of ATG7 reverses the inhibitory effect of miR-582-5p on gastric cancer.Conclusion: Our study confirms that microRNA-582-3p acts as a tumor suppressor in gastric cancer cells, and its role may be mediated through the regulation of ATG7 expression levels. MicroRNA-582-3p may serve as a potential target for gastric cancer treatment and a predictive biomarker.
- 11 October 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1481266
Open AccessMicroRNA-582-5p inhibits the progression of gastric cancer cells and their resistance to oxaliplatin by suppressing ATG7 expression
Background: Gastric cancer (GC) is one of the most common malignant tumors of the digestive tract worldwide. Both environmental and genetic factors contribute to the occurrence and development of GC. Surgery and chemotherapy are the main treatment modalities for gastric cancer; however, some patients show insensitivity to chemotherapeutic agents. Chemotherapy resistance is one of the primary reasons for poor treatment outcomes and the high likelihood of recurrence and metastasis in gastric cancer patients. Numerous studies have confirmed a correlation between the dysregulation of microRNA expression and the development of various malignant tumors, as well as their resistance to chemotherapeutic agents. However, the role of microRNA-582-3p in gastric cancer cells and its mechanism in the resistance of gastric cancer cells to oxaliplatin have not been studied.Methods: We first used q-PCR, CCK8, transwell, and scratch assays to validate the expression of microRNA-582-3p in gastric cancer tissues and cells, while also analyzing the relationship between its expression levels and the clinical pathological data of patients. Additionally, we further confirmed the impact of microRNA-582-3p on gastric cancer cell progression and oxaliplatin resistance through knockdown and overexpression experiments. Subsequently, to explore the specific mechanisms of microRNA-582-3p in gastric cancer, we verified the downstream target of microRNA-582-3p, ATG7, using dual-luciferase reporter assays and examined the effect of ATG7 on gastric cancer cell functions. Moreover, we conducted rescue experiments to further validate the interaction between microRNA-582-3p and ATG7.Results: Our experimental results confirmed that microRNA-582-3p is lowly expressed in gastric cancer tissues and cells, and the expression level of miR-582-5p is correlated with the T stage of patients, while showing no correlation with the patients' gender, age, tumor size, degree of differentiation, or N stage. Additionally, we found that microRNA-582-3p functions as a tumor suppressor in gastric cancer cells, as its overexpression inhibits the biological functions of gastric cancer cells and increases their sensitivity to oxaliplatin. Furthermore, we identified binding sites between microRNA-582-3p and the autophagy-related gene ATG7, observing that knockdown of microRNA-582-3p increases ATG7 expression, while its overexpression reduces ATG7 levels. Moreover, ATG7 is overexpressed in gastric cancer cells; knockdown of ATG7 inhibits the biological functions of gastric cancer cells and increases their sensitivity to oxaliplatin, whereas overexpression of ATG7 reverses the inhibitory effect of miR-582-5p on gastric cancer.Conclusion: Our study confirms that microRNA-582-3p acts as a tumor suppressor in gastric cancer cells, and its role may be mediated through the regulation of ATG7 expression levels. MicroRNA-582-3p may serve as a potential target for gastric cancer treatment and a predictive biomarker.